Assessment of aminoglycosides and β-lactam resistance genes among uropathogens; a prospective-cross sectional study
Abstract
Urinary tract infections (UTIs) represent a major public health challenge worldwide, accounting for millions of outpatient consultations and substantial healthcare expenditure annually. In this prospective cross-sectional investigation conducted from February 2019 to January 2020 at a tertiary-care hospital in Islamabad, Pakistan, we examined the etiological agents of UTI, their antimicrobial susceptibility profiles, and the occurrence of the aminoglycoside resistance genes aac(6’)-Ib-cr and the β-lactam resistance genes blaTEM among 503 patients with suspected UTI. Culture-confirmed UTI was established in 127 patients (25.2%; 95% CI 21.5–29.3%), with markedly higher prevalence in females (33.6%) than males (16.8%; P < 0.001). Of these, 16 (12.6%) yielded polymicrobial growth. Gram-negative bacilli predominated (110/127 isolates, 86.6%), led by Escherichia coli (91/127, 71.7%), followed by Klebsiella spp. (9/127, 7.1%), Proteus spp. (6/127, 4.7%), and Pseudomonas spp. (4/127, 3.1%). Among Gram-negative isolates, susceptibility was highest to cefepime (75.8%) and cefoxitin (68.1%), whereas resistance exceeded 65% against gentamicin, ampicillin, ceftriaxone, and ciprofloxacin, with 68.1% classified as multidrug-resistant. Gram-positive isolates retained full susceptibility to imipenem and vancomycin. These findings underscore the urgent requirement for routine culture-guided therapy, enhanced antimicrobial stewardship, and continuous local surveillance to mitigate the…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 503 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.